High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.

ABSTRACT:

SUBMITTER: Khwaja J 

PROVIDER: S-EPMC9445042 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature